View Author
igf-i level growth insulin study igfbp serum igf-i levels patient subject factor hormone effect receptor diabetes insulin-like glucose concentration ghrelin blood endocrinol protein group allele igfbp -3 levels igf-i bioactivity fasting binding polymorphism metab table growth hormone control disease result treatment bioactivity assay type 2 diabetes change population carrier endocrinology igfbp -3 acromegaly value genotype journal insulin-like growth factor-i baseline difference cancer activity rotterdam insulin-like growth factors adult increase sample 22/23ek carriers system relationship secretion plasma administration measurement serum igf-i levels range association igf-i receptor women pegvisomant pressure hypertension sensitivity signi 192- bp allele decrease metabolism diabetes mellitus igf-ir
10 Most Recent Publications
|
Effect of intensive insulin therapy on the somatotropic axis of critically ill children
(Article)
Gielen, M. Mesotten, D. Brugts, M.P. Coopmans, W. Herck, E. van Vanhorebeek, I. Baxter, R. Lamberts, S.W.J. Janssen, J.A.M.J.L. Berghe, G. van den |
2011-08-01
|
|
IGF-I bioactivity better reflects growth hormone deficiency than total IGF-I
(Article)
Varewijck, A.J. Lamberts, S.W.J. Uitterlinden, P. Hofland, L.J. Janssen, J.A.M.J.L. |
2011-07-01
|
|
Insulin-like growth factor I: Pros and cons of a bioassay
(Article)
Janssen, J.A.M.J.L. |
2011-07-01
|
|
Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir
(Article)
Varewijck, A.J. Goudzwaart, J.A. Brugts, M.P. Lamberts, S.W.J. Hofland, L.J. Janssen, J.A.M.J.L. |
2010-12-01
|
|
Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients
(Article)
Brugts, M.P. Tjiong, H.L. Rietveld, T. Wattimena, J.L. Berg, J.W.O. van den Fieren, M.W.J.A. Janssen, J.A.M.J.L. |
2010-03-01
|
|
Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir
(Article)
Varewijck, A.J. Goudzwaart, J.A. Brugts, M.P. Lamberts, S.W.J. Hofland, L.J. Janssen, J.A.M.J.L. |
2010-01-01
|
|
Advantages and disadvantages of GH/IGF-I combination treatment
(Article)
Janssen, J.A.M.J.L. |
2009-06-01
|
|
Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells
(Article)
Vitale, G. Koetsveld, P.M. van Herder, W.W. de Wansem, K. van der Janssen, J.A.M.J.L. Colao, A. Lombardi, G. Lamberts, S.W.J. Hofland, L.J. |
2009-03-01
|
|
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant
(Article)
Neggers, S.J.C.M.M. Aken, M.O. van Herder, W.W. de Feelders, R.A. Janssen, J.A.M.J.L. Badia, X. Webb, S.M. Lely, A.J. van der |
2008-10-01
|
|
Low Circulating IGF-I Bioactivity in Elderly Men is associated with Increased Mortality
(Article)
Brugts, M.P. Beld, A.W. van den Hofland, L.J. Wansem, K. van der Koetsveld, P.M. van Frystyk, J. Lamberts, S.W.J. Janssen, J.A.M.J.L. |
2008-07-01
|
